Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, I'm going to explain why UBER stock is the best quality stock to buy in the stock market

1 extracted signal · 1 resolved · 0 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
07 Aug 2025, 18:15 UTC
Recorded by Tahlil Plus
18 May 2026, 20:23 UTC
Video preview for Friends! In this video, I'm going to explain why UBER stock is the best quality stock to buy in the stock market
Source overview

AI-generated source summary

This analysis focuses on Uber's fundamentals and potential. It notes that Uber is trading at a low multiple, 17 times cash flow, and highlights the company's changing business models as a positive factor. It references the most recent earnings with an 18% revenue increase and how there is a massive ramp up in adjusted EBITDA and mentions delivery up 20%. It mentions the 3 main business models to explain what autonomous vehicles are and how that affects the company, they plan to use 50% of their free cash flow to buy back stock. The analysis suggests a possible near-term target of $100, with a growth rate for the near future of 20% which may change his previous thesis.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
1
Extracted from this source
Open
0
Still being tracked
Successful
1
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
100%
1 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    1 eligible signal linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.9
Tracked signals
355
Historical success
34.9%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail